Madden Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-535
Closed -$56K 124
2017
Q1
$56K Buy
+535
New +$53.6K 0.04% 119
2015
Q4
Sell
-955
Closed -$96K 142
2015
Q3
$96K Hold
955
0.06% 104
2015
Q2
$118K Buy
+955
New +$115K 0.07% 103
2015
Q1
Sell
-955
Closed -$97K 139
2014
Q4
$97K Hold
955
0.06% 112
2014
Q3
$88K Hold
955
0.05% 129
2014
Q2
$79K Buy
955
+35
+4% +$2.68K 0.04% 135
2014
Q1
$71K Buy
920
+35
+4% +$2.73K 0.04% 124
2013
Q4
$61K Sell
885
-86
-9% -$5.64K 0.05% 118
2013
Q3
$63K Hold
971
0.05% 96
2013
Q2
$57K Buy
+971
New +$55.5K 0.05% 103

Other funds holding FBT

Madden Advisory Services's FBT Position: Q2 2017 in Review

Madden Advisory Services sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2017, closing a stake of 535 shares — an estimated $56K sold.

Madden Advisory Services first reported a position in FBT in Q2 2013 and held it in 10 quarters. The position peaked at $118K in Q2 2015. 112 funds tracked by Wall St. Rank hold FBT as of Q2 2017.

  • Madden Advisory Services reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2017 after selling out during the quarter.
  • Madden Advisory Services sold 535 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2017, an estimated $56K.
  • Madden Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 10 quarters.
  • Madden Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $118K in Q2 2015.
  • 112 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2017.

Based on Madden Advisory Services's 13F filing for Q2 2017, filed 11 Aug 2017.